Vol 11, No 1 (January 26, 2022): Translational Lung Cancer Research

Original Article

TP53 co-mutations as an independent prognostic factor in 2nd and further line therapy—EGFR mutated non-small cell lung cancer IV patients treated with osimertinib
Julia Roeper, Petros Christopoulos, Markus Falk, Lukas C. Heukamp, Markus Tiemann, Albrecht Stenzinger, Michael Thomas, Frank Griesinger
Malignant thoracic lymph node classification with deep convolutional neural networks on real-time endobronchial ultrasound (EBUS) images
Seung Hyun Yong, Sang Hoon Lee, Sang-Il Oh, Ji-Soo Keum, Kyung Nam Kim, Moo Suk Park, Yoon Soo Chang, Eun Young Kim
A prediction model integrated genomic alterations and immune signatures of tumor immune microenvironment for early recurrence of stage I NSCLC after curative resection
Chunhong Hu, Long Shu, Chen Chen, Songqing Fan, Qingchun Liang, Hongmei Zheng, Yue Pan, Lishu Zhao, Fangwen Zou, Chaoyuan Liu, Wenliang Liu, Feng-Lei Yu, Xianling Liu, Lijuan Liu, Lingling Yang, Yang Shao, Fang Wu
Prognostic significance of procalcitonin in small cell lung cancer
Kosuke Ichikawa, Satoshi Watanabe, Satoru Miura, Aya Ohtsubo, Satoshi Shoji, Koichiro Nozaki, Tomohiro Tanaka, Yu Saida, Rie Kondo, Satoshi Hokari, Nobumasa Aoki, Yasuyoshi Ohshima, Toshiyuki Koya, Toshiaki Kikuchi
Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study
Mariano Provencio, Delvys Rodríguez-Abreu, Ana L. Ortega, Gloria Serrano, Carlos Aguado, Fernando Franco, Vanesa Gutierrez, Guillermo López Vivanco, María Guirado, Gretel Benítez, Anna Estival, Virginia Calvo, Beatriz Jiménez, Hugo Arasanz, Juan Coves, Margarita Majem, Bartomeu Massutí, Sergio Vázquez, Oscar Juan-Vidal, Ana Collazo-Lorduy, Clara L. Gozálvez, Edel Del Barco, Adriana Rosero, Joaquim Bosch-Barrerra, María A. Moreno, Xabier Mielgo-Rubio, José C. Villa, Ana López-Martin, Juan F. Córdoba, Francisco de Asís Aparisi, Marta Zafra, Joaquín Mosquera, Javier Pérez Altozano, Ernest Nadal, Silvia Catot, José Balsalobre, Teresa de Portugal, Paloma Martín, Susana Cuesta de Juan, Manuel Cobo
The presence of lepidic and micropapillary/solid pathological patterns as minor components has prognostic value in patients with intermediate-grade invasive lung adenocarcinoma
Yucheng Hou, Weijian Song, Mingzhi Chen, Jianfeng Zhang, Qingquan Luo, Sang-Won Um, Francesco Facchinetti, Stefano Bongiolatti, Qianjun Zhou
A nomogram to predict the recurrence-free survival and analyze the utility of chemotherapy in stage IB non-small cell lung cancer
Zhenyang Zhang, Shuhan Xie, Weijing Cai, Zhi-Nuan Hong, Chuangcai Yang, Yukang Lin, Jiafu Zhu, Zhiwei Lin, Daniel C. Christoph, Hanibal Bohnenberger, Lucyna Kepka, Wolfgang M. Brueckl, Paul Van Houtte, Mingqiang Kang, Jiangbo Lin
Pembrolizumab monotherapy or combination therapy for bone metastases in advanced non-small cell lung cancer: a real-world retrospective study
Huiping Qiang, Yuqiong Lei, Yinchen Shen, Jiaqi Li, Hua Zhong, Runbo Zhong, Xueyan Zhang, Qing Chang, Jiahuan Lu, Hui Feng, Yan Zhu, Alfredo Addeo, Giuseppe L. Banna, In-Jae Oh, Jialin Qian, Tianqing Chu

Editorial Commentary

Smoking burden, MPOWER, future tobacco control and real-world challenges in China: reflections on the WHO report on the global tobacco epidemic 2021
Kaiping Zhang, Alfredo Tartarone, Mónica Pérez-Ríos, Silvia Novello, Annapaola Mariniello, Giandomenico Roviello, Jianrong Zhang